Cyberknife image-guided delivery and quality assurance

Area of Science:

• Medical Physics
• Radiation Oncology
• Radiotherapy Technology

Background:

• The CyberKnife represents a novel approach in image-guided radiotherapy, differing significantly from traditional stereotactic radiosurgery and external beam radiotherapy.
• Its current clinical application and quality assurance (QA) practices position it between established stereotactic radiosurgery and radiotherapy techniques.
• A notable challenge in CyberKnife implementation is the scarcity of vendor-independent QA recommendations and published data, particularly concerning component interactions.

Purpose of the Study:

• To discuss the current status of quality assurance (QA) guidelines for the clinical implementation of the CyberKnife system.
• To provide insights from an active clinical and research site utilizing the CyberKnife.
• To highlight the need for developing comprehensive QA guidance for this emerging technology.

Main Methods:

• Review of current clinical QA practices for the CyberKnife system.
• Analysis of vendor-provided guidance for QA procedures.
• Discussion of the challenges and ongoing development in CyberKnife QA tools and techniques.
• Perspective from an active clinical and research site.

Main Results:

• Clinical QA for the CyberKnife predominantly follows vendor recommendations due to a lack of independent guidelines.
• There is limited published data available for CyberKnife QA, especially for inter-component interactions.
• QA tools and techniques are under continuous development, necessitating adaptation as the technology evolves.

Conclusions:

• The CyberKnife's evolving nature requires continuous adaptation of its quality assurance (QA) protocols.
• Developing vendor-independent QA recommendations and a database of user-reported errors is crucial for advancing CyberKnife safety and efficacy.
• Further research and shared clinical experience are essential for establishing robust QA guidelines.